• Bicycle Therapeutics Limited, a UK biotechnology company, in the negotiation of a collaboration agreement with Bioverativ Inc. to discover, develop and commercialize innovative therapies for hemophilia and sickle cell disease in a deal worth $424.2 million plus royalties.
    • Business Development Corporation of America, a non-traded business development company, in its issuance of $150 million of senior unsecured notes, which was followed by an offering of $60 million of additional senior unsecured notes.
    • Differential Brands Group Inc., a NASDAQ-listed corporation now known as Centric Brands Inc., in its purchase of the majority of the North American wholesale, retail and e-commerce operations of Global Brands Group Holding Limited, a Hong-Kong listed branded apparel, footwear and fashion accessories company, for a purchase price of $1.38 billion.
    • GIC in its acquisition of a substantial equity stake (along with Silver Lake) in Ancestry.com, a provider of online family history data and personal DNA testing.
    • Griffon Corporation in the acquisition of ClosetMaid Corporation, a market leader of home storage and organization products, from Emerson Electric Co. 
    • Griffon Corporation and its affiliates in connection with the acquisition of CornellCookson, a leading U.S. manufacturer and marketer of rolling steel door and grille products designed for commercial, industrial, institutional, and retail use.
    • Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, in a divestiture of rights and assets with respect to a respiratory diagnostic assay panel to Biocartis NV, a Belgian company.
    • Keefe, Bruyette & Woods, a subsidiary of Stifel Financial Corp, as lead underwriter and joint book-running manager, in respect of the issuance of $34.5 million in senior unsecured notes by CM Finance Inc, a BDC listed on the NASDAQ Global Select Market.
    • Monster Worldwide Inc., a publicly traded global online employment solution company, in its US$429 million sale to an affiliate of Randstad Holding nv.
    • Public Pension Capital (PPC) in connection with its acquisition of Viteos Fund Services, a leading provider of middle- and back-office technology and services for the investment management industry.
    • Remedy Pharmaceuticals, Inc., a privately-held, clinical stage pharmaceutical company, in a sale of substantially all of its assets to a wholly-owned subsidiary of Biogen Inc., in a deal worth $120 plus development and sales milestone payments and royalties. 
    • Steadview Capital Management in its minority equity investment in Dream11, Inc., the owner of a fantasy sports website.